Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENT-01 for Parkinson's Disease-Related Constipation
NCT03781791Phase 2Completed
- Sponsor
- Enterin Inc.
- Start
- Dec 2018
- Primary completion
- Dec 2021
- Modality
- Multivalent & Scaffold-Based Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of squalamine in constipation, sponsored by Enterin Inc.. Started Dec 2018; status: completed.
02
Drugs
squalamine
03
Conditions
constipation
Beyond the preview
Go deeper on NCT03781791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03781791.